Chimeric antigen receptor T-cell therapy following autologous transplantation for secondary central nervous system lymphoma: A case report.

Yu YagiYusuke KanemasaAn OhigashiYuka MoritaTaichi TamuraShohei NakamuraYuki OtsukaYuya KishidaAkihiko KageyamaTakuya ShimizuguchiTakashi ToyaHiroaki ShimizuYuho NajimaTakeshi KobayashiKyoko HaraguchiNoriko DokiYoshiki OkuyamaYasushi OmuroTatsu Shimoyama

Published in: Medicine (2022)

CAR T-cell therapy following autologous stem cell transplantation is a viable option for relapsed/refractory lymphoma with CNS infiltration. Further clinical studies are warranted to verify its safety and efficacy.

Keyphrases

cell therapy
stem cell transplantation
diffuse large b cell lymphoma
high dose
stem cells
mesenchymal stem cells
acute lymphoblastic leukemia
acute myeloid leukemia
multiple myeloma
blood brain barrier
hodgkin lymphoma
bone marrow
low dose
cerebrospinal fluid
replacement therapy